|

US Pres. Trump: Vaccine may be approved `very, very soon'

During his press conference on early Wednesday in Asia, US President Donald Trump rekindled hopes of the coronavirus (COVID-19) vaccine while citing an agreement with Kodak.

Key quotes

Historic agreement being reached with Kodak to produce critical pharmaceuticals.

DPA being used to give $675 million loan to launch Kodak pharmaceuticals.

The US government deal with Kodak for pharmaceutical ingredients is his 33rd use of the defense production act.

Vaccine may be approved "very,very soon".

Pfizer's vaccine is going in the right direction.

Today's action is our latest step to create the greatest medical arsenal in history.

Coronavirus numbers will be going down soon.

We will make America the world's premier medical manufacturer and supplier.

Not a single American who has needed a ventilator has been denied a ventilator.

We'll have 500 million doses of a COVID-19 vaccine.

Perhaps we'll be supplying" other parts of the world with the vaccine.

The pharmaceutical arm of Kodak will make "general, active pharmaceutical ingredients" that are the "key starting materials that are the building blocks for many drug.

Some aspects of Republican coronavirus relief bill that do not support. (Doesn't specify the details.)

Think hydroxychloroquine works in the early stages of infection.

For the most part, the administration has done what Dr. Fauci and coronavirus task force coordinator BIRX have recommended.

Going to take care of the people' when asked about expiring federal unemployment benefits.

FX implications

The news confronts the previous downbeat news, suggesting a further delay in the US fiscal package, which in turn helped AUD/USD remain afloat in the middle of the 0.7100.

Author

Anil Panchal

Anil Panchal

FXStreet

Anil Panchal has nearly 15 years of experience in tracking financial markets. With a keen interest in macroeconomics, Anil aptly tracks global news/updates and stays well-informed about the global financial moves and their implications.

More from Anil Panchal
Share:

Editor's Picks

EUR/USD trims gains, back below 1.1800

EUR/USD now loses some upside momentum, returning to the area below the 1.1800 support as the Greenback manages to regain some composure following the SCOTUS-led pullback earlier in the session.

GBP/USD off highs, recedes to the sub-1.3500 area

Following earlier highs north of 1.3500 the figure, GBP/USD now faces some renewed downside pressure, revisiting the 1.3490 zone as the US Dollar manages to regain some upside impulse in the latter part of the NA session on Friday.

Gold climbs to weekly tops, approaches $5,100/oz

Gold keeps the bid tone well in place at the end of the week, now hitting fresh weekly highs and retargeting the key $5,100 mark per troy ounce. The move higher in the yellow metal comes in response to ongoing geopolitical tensions in the Middle East and modest losses in the US Dollar.

Crypto Today: Bitcoin, Ethereum, XRP rebound as risk appetite improves

Bitcoin rises marginally, nearing the immediate resistance of $68,000 at the time of writing on Friday. Major altcoins, including Ethereum and Ripple, hold key support levels as bulls aim to maintain marginal intraday gains.

Week ahead – Markets brace for heightened volatility as event risk dominates

Dollar strength dominates markets as risk appetite remains subdued. A Supreme Court ruling, geopolitics and Fed developments are in focus. Pivotal Nvidia earnings on Wednesday as investors question tech sector weakness.

Ripple bulls defend key support amid waning retail demand and ETF inflows

XRP ticks up above $1.40 support, but waning retail demand suggests caution. XRP attracts $4 million in spot ETF inflows on Thursday, signaling renewed institutional investor interest.